; (11): 762-76, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15652036
A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.
Weight loss medications--where do they fit in?
Diethylpropion and mazindol: An end to the discussion?
The efficacy of the appetite suppressant, diethylpropion, is dependent on both when it is given (day vs. night) and under conditions of high fat dietary restriction.
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety.
Pharmacological and surgical treatment of obesity.
A comparison of mazindol (Teronac) with diethylpropion in the treatment of exogenous obesity.